MEETINGS - Extended newborn screening - anticipating the future (UK) February 2005:
This article was originally published in Clinica
Executive Summary
The UK's Royal Society of Medicine is holding an open meeting on Extended newborn screening - anticipating the future, in London, on February 22 2005. Key topics of the discussion will be the "power of new technologies to extend the scope of neonatal screening", the diseases to which this might be extended and, in particular, issues surrounding screening for cystic fibrosis. For more information and web-based registration, see www.rsm.ac.uk, or contact the RSM on tel: +44 (0)20 7290 2986/2982; fax: +44 (0)20 7290 2989.
You may also be interested in...
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.
Taro Agrees $36m Securities Settlement Over US Price-Fixing Claims
Sun’s Taro subsidiary is looking to move forward with an eight-figure settlement deal in the US, after plaintiffs including a firefighters’ pension fund accused the firm of misleading investors via its involvement in generic price fixing, leading to a fall in the price of its securities.
As Casgevy, Lyfgenia Launches Proceed, CRISPR And bluebird bio CEOs Reassure
The CEOs of bluebird bio and CRISPR Therapeutics hope to inspire investor confidence that their gene-based therapies for sickle cell disease and beta thalassemia will be widely reimbursed in the US and EU.